Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-001259
Filing Date
2013-01-03
Accepted
2013-01-03 17:51:49
Documents
1
Period of Report
2012-09-07

Document Format Files

Seq Description Document Type Size
1 rrd365039.html 4  
1 rrd365039.xml 4 18141
  Complete submission text file 0001181431-13-001259.txt   19641
Mailing Address 5350 S ROSLYN SUITE 380 ENGLEWOOD CO 80111
Business Address
BATHGATE STEVEN MARK (Reporting) CIK: 0001011938 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52530 | Film No.: 13508638

Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Issuer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)